These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6688545)

  • 21. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
    Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
    Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The unique action for bone metabolism of 1 alpha,25-(OH)2D3-26,23-lactone.
    Kiyoki M; Kurihara N; Ishizuka S; Ishii S; Hakeda Y; Kumegawa M; Norman AW
    Biochem Biophys Res Commun; 1985 Mar; 127(2):693-8. PubMed ID: 3838477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone histomorphometry in 1,25(OH)2D3- and vitamin D3-treated aged laying hens.
    Newbrey JW; Truitt ST; Roland DA; Frost TJ; Untawale GG
    Avian Dis; 1992; 36(3):700-6. PubMed ID: 1329713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 1,25-dihydroxyvitamin D3 on biochemical indices of bone turnover in postmenopausal women.
    Tjellesen L; Christiansen C; Rødbro P
    Acta Med Scand; 1984; 215(5):411-5. PubMed ID: 6547563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 24R,25-dihydroxyvitamin D3 promotes bone formation without causing excessive resorption in hypophosphatemic mice.
    Ono T; Tanaka H; Yamate T; Nagai Y; Nakamura T; Seino Y
    Endocrinology; 1996 Jun; 137(6):2633-7. PubMed ID: 8641218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term course of 1,25(OH)2D3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis.
    Geusens P; Vanderschueren D; Verstraeten A; Dequeker J; Devos P; Bouillon R
    Calcif Tissue Int; 1991 Sep; 49(3):168-73. PubMed ID: 1933581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of 24,25-dihydroxyvitamin D3 in osteoclasts.
    Matsumoto T; Yamato H; Okazaki R; Kumegawa M; Ogata E
    Proc Soc Exp Biol Med; 1992 Jun; 200(2):161-4. PubMed ID: 1579577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption.
    Gallagher JA; Beneton M; Harvey L; Lawson DE
    Endocrinology; 1986 Oct; 119(4):1603-9. PubMed ID: 3757903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of bone tissue in rats treated by prednisolone and 1,25-(OH)2D3.
    Lindgren JU; Johnell O; DeLuca HF
    Clin Orthop Relat Res; 1983 Dec; (181):264-8. PubMed ID: 6688979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse.
    Marie PJ; Travers R; Glorieux FH
    Endocrinology; 1982 Sep; 111(3):904-11. PubMed ID: 6896684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).
    Duque G; Macoritto M; Dion N; Ste-Marie LG; Kremer R
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E723-30. PubMed ID: 15572658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M; Hock JM; Gera I; Fonseca J; Poser J; Bevan J; Raisz LG
    Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different responses of trabecular and cortical bone to 1,25(OH)2D3 infusion.
    Bikle DD; Halloran BP; McGalliard-Cone C; Morey-Holton E
    Am J Physiol; 1990 Nov; 259(5 Pt 1):E715-22. PubMed ID: 2240210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
    Endo K; Katsumata K; Hirata M; Masaki T; Kubodera N; Nakamura T; Ikeda K; Ogata E
    J Bone Miner Res; 2000 Jan; 15(1):175-81. PubMed ID: 10646127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats.
    Gunness-Hey M; Gera I; Fonseca J; Raisz LG; Hock JM
    Calcif Tissue Int; 1988 Nov; 43(5):284-8. PubMed ID: 3145794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of low doses of stable strontium on bone metabolism in rats.
    Marie PJ; Garba MT; Hott M; Miravet L
    Miner Electrolyte Metab; 1985; 11(1):5-13. PubMed ID: 3974537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
    van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
    J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased clearance of 1,25(OH)2D3 and tissue-specific responsiveness to 1,25(OH)2D3 in diabetic rats.
    Verhaeghe J; Suiker AM; Van Bree R; Van Herck E; Jans I; Visser WJ; Thomasset M; Allewaert K; Bouillon R
    Am J Physiol; 1993 Aug; 265(2 Pt 1):E215-23. PubMed ID: 8368291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased intestinal absorption of calcium in young and adult X-linked hypophosphatemic mice after the administration of 1,25-dihydroxyvitamin D3.
    Meyer MH; Meyer RA
    J Bone Miner Res; 1988 Apr; 3(2):151-7. PubMed ID: 3213610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.